Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.

Paul HsuEunice J ChoiShefali A PatelWilliam H WongJocelyn G OlveraPriscilla YaoYi Chia LiuMatthew S TsaiWei WangBrigid S BolandJohn T Chang

Published in: Inflammatory bowel diseases (2023)

Overall, our results indicate that efforts to elucidate cell-cell communications among immune and nonimmune cell types may increase the mechanistic understanding of current and investigational therapies for IBD.

Keyphrases

single cell
cell therapy
ulcerative colitis
stem cells
bone marrow
clinical trial
study protocol
phase ii